HKUMed Unveils Broader Potential of Fatty Liver Medication in Liver Cancer Prevention and Treatment
A groundbreaking study from researchers at the University of Hong Kong’s School of Clinical Medicine reveals that Resmetirom, an FDA-approved ...
A groundbreaking study from researchers at the University of Hong Kong’s School of Clinical Medicine reveals that Resmetirom, an FDA-approved ...
Recent research illuminates the significant role that aerobic exercise plays in managing Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). A comprehensive ...
Recent advancements in the understanding of metabolic dysfunction-associated fatty liver disease (MAFLD) have revealed intricate connections with serum uric acid ...
In a groundbreaking study published in Military Medical Research, researchers led by Miao et al. have uncovered the vital role ...
In a groundbreaking development that could revolutionize the treatment of chronic liver diseases, researchers have identified a symbiotic filamentous fungus ...
Metabolic dysfunction-associated fatty liver disease (MAFLD), previously known as non-alcoholic fatty liver disease (NAFLD), represents a significant global health challenge, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine